These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11283673)

  • 1. Generation of HIV latency during thymopoiesis.
    Brooks DG; Kitchen SG; Kitchen CM; Scripture-Adams DD; Zack JA
    Nat Med; 2001 Apr; 7(4):459-64. PubMed ID: 11283673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice.
    Kollmann TR; Kim A; Pettoello-Mantovani M; Hachamovitch M; Rubinstein A; Goldstein MM; Goldstein H
    J Immunol; 1995 Jan; 154(2):907-21. PubMed ID: 7814892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals.
    Chun TW; Justement JS; Lempicki RA; Yang J; Dennis G; Hallahan CW; Sanford C; Pandya P; Liu S; McLaughlin M; Ehler LA; Moir S; Fauci AS
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1908-13. PubMed ID: 12552096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired replication of protease inhibitor-resistant HIV-1 in human thymus.
    Stoddart CA; Liegler TJ; Mammano F; Linquist-Stepps VD; Hayden MS; Deeks SG; Grant RM; Clavel F; McCune JM
    Nat Med; 2001 Jun; 7(6):712-8. PubMed ID: 11385509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prostratin on T-cell activation and human immunodeficiency virus latency.
    Korin YD; Brooks DG; Brown S; Korotzer A; Zack JA
    J Virol; 2002 Aug; 76(16):8118-23. PubMed ID: 12134017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of human immunodeficiency virus infection of CD8 lymphocytes expressing CD4 in vivo.
    Cochrane A; Imlach S; Leen C; Scott G; Kennedy D; Simmonds P
    J Virol; 2004 Sep; 78(18):9862-71. PubMed ID: 15331721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The SCID-hu mouse as a model for HIV-1 infection.
    Aldrovandi GM; Feuer G; Gao L; Jamieson B; Kristeva M; Chen IS; Zack JA
    Nature; 1993 Jun; 363(6431):732-6. PubMed ID: 8515816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.
    Thibault S; Imbeault M; Tardif MR; Tremblay MJ
    Virology; 2009 Jun; 389(1-2):20-5. PubMed ID: 19447460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual activity of phosphorothioate CpG oligodeoxynucleotides on HIV: reactivation of latent provirus and inhibition of productive infection in human T cells.
    Scheller C; Ullrich A; Lamla S; Dittmer U; Rethwilm A; Koutsilieri E
    Ann N Y Acad Sci; 2006 Dec; 1091():540-7. PubMed ID: 17341643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 infection, response to treatment and establishment of viral latency in a novel humanized T cell-only mouse (TOM) model.
    Honeycutt JB; Wahl A; Archin N; Choudhary S; Margolis D; Garcia JV
    Retrovirology; 2013 Oct; 10():121. PubMed ID: 24156277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between changes in thymic emigrants and cell-associated HIV-1 DNA in HIV-1-infected children initiating antiretroviral therapy.
    De Rossi A; Walker AS; De Forni D; Klein N; Gibb DM;
    Antivir Ther; 2005; 10(1):63-71. PubMed ID: 15751764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy.
    Delobel P; Nugeyre MT; Cazabat M; Sandres-Sauné K; Pasquier C; Cuzin L; Marchou B; Massip P; Cheynier R; Barré-Sinoussi F; Izopet J; Israël N
    J Virol; 2006 Oct; 80(20):10229-36. PubMed ID: 17005700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porcine thymic grafts protect human thymocytes from HIV-1-induced destruction.
    Hongo D; Hadidi S; Damrauer S; Garrigue V; Kraft D; Sachs DH; Nikolic B; Sykes M
    J Infect Dis; 2007 Sep; 196(6):900-10. PubMed ID: 17703422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 DNA and RNA kinetics in primary HIV infection.
    Lillo F; Grasso M; Lodini S; Capiluppi B; Lazzarin A; Tambussi G
    J Biol Regul Homeost Agents; 2002; 16(1):49-52. PubMed ID: 12003174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimeric toxins targeted to the human immunodeficiency virus type 1 envelope glycoprotein augment the in vivo activity of combination antiretroviral therapy in thy/liv-SCID-Hu mice.
    Goldstein H; Pettoello-Mantovani M; Bera TK; Pastan IH; Berger EA
    J Infect Dis; 2000 Mar; 181(3):921-6. PubMed ID: 10720513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of latent human immunodeficiency virus infection on cell surface phenotype.
    Brooks DG; Zack JA
    J Virol; 2002 Feb; 76(4):1673-81. PubMed ID: 11799162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.